The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Intellectual property litigation and counseling services for a major world chemical producer
Represent a Fortune 500 company and major world producer of chemicals, fibers and plastics, by providing a full range of intellectual more
Sale of interest in a joint venture
Represented Miller Industries, Inc. (NYSE: MLR) in its March 2014 sale of all of its interest in a manufacturing joint venture to its joint venture more
Banking and financial services for servicers and lenders
Represents servicers and lenders in post-origination loan modifications, loan assumptions, and loan defeasances. more
Ewald v. DaimlerChrysler Corp.
Represented DaimlerChrysler Corporation when the owner of the RUBICON mark for cargo trailers sought to enjoin our client from using RUBICON for more